Pure Global
NCT06381349

Predicting Outcomes of GPOEM Using Gastric Electrical Mapping

Predicting Outcomes of Gastric Peroral Endoscopic Myotomy Using a Gastric Electrical Mapping System: GPOEM-GEMS
Chris Varghese·ClinicalTrials.gov·diagnostic testNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Gastroparesis
Drug/Device/Intervention
Gastric Alimetry test
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Chris Varghese
Funder
University of Auckland, New Zealand
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Jun 01, 2026
Enrollment
300 participants
Primary outcome

Gastroparesis Cardinal Symptom Index (GCSI)

Summary

Gastric peroral endoscopic myotomy (GPOEM) is a minimally-invasive procedure that involves
 dividing the pylorus, to enhance gastric emptying in gastroparesis patients. This is a
 single-arm, multi-centre, prospective observational study to determine the clinical utility
 of Gastric Alimetry in predicting GPOEM treatment outcomes. The investigators further aim to
 develop a clinical decision rule to inform patient selection. Gastric Alimetry will be
 conducted 1 month prior to GPOEM. All subjects will then be followed up for 12 months.

ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06381349
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06381349 through Pure Global AI's free database. This phase not specified trial is sponsored by Chris Varghese and is currently Not yet recruiting. The study focuses on Gastroparesis. Target enrollment is 300 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.